Cell Based Assays: the latest in Phenotypic, 3D and Ion Channel based cellular assays

Share Article

GlaxoSmithKline, Boehringer-Ingleheim, Actelion, Novartis, AstraZeneca and many others confirmed their participation in SMi’s 6th annual Cell Based Assays Conference in London.

News Image
"A well organised conference with some very interesting and good talks." Abbott

Following on from its hugely successful Cell-Based Assays Conference in 2012, this year's event, taking place on the 18th-19th of November 2013 in London, UK, will feature over 16 innovative presentations delivered by some of the leading names in the Pharma industry, discussing 3D cell culture, future screening tools and primary phenotypic assays, drug design, targeting ION channels and novel technologies in the latest Cell Based Assays platforms.

Interactive post-conference workshop “Overcoming the challenges of moving from 2D to 3D cells based Assays in an HCS and HTS environment” will be taking place on the 20th of November, hosted by Anthony Davies, Director, Trinity College Dublin.

Top 4 Reasons to Attend:

  • Hear the latest on Phenotypic screening; how target based screening is allowing for identification of small molecules
  • See how you can implement a primary cell assay plan through a case study of SAR-driving assay
  • The latest in GPCR and other ion channel targeting pathways and how they are being used in the most recent drug discovery assays
  • Adopt accelerated primary cell screening systems such as those utilised by GSK

Keynote speakers include:

  • Mao Xiang Chen, Biological and Cellular targets, GlaxoSmithKline
  • Martha Brown, Senior Associate Director, Boehringer-Ingelheim
  • Xavier Leroy, Director, Actelion
  • Steve Ludbrook, Section Head, GlaxoSmithKline
  • Urs Luethi, Senior Lab Head Discovery, Actelion
  • Anthony Davies, Director, Trinity College Dublin
  • Tyrell Norris, Team Leader – Cellular Reagents & Assay Development, AstraZeneca
  • Amir Gander, Senior Knowledge Transfer Associate, University College London

For the full conference programme and further information please visit:
http://www.smi-online.co.uk/goto/2013cellbasedassay51.asp

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email: fbegum(at)smi-online(dot)co(dot)uk

Sponsorship opportunities are available for this event, please contact Alia Malick on +44(0) 20 7827 6168.

Contact for media-partners: Julia Rotar, jrotar(at)smi-online(dot)co(dot)uk, +44 (0) 20 7827 6088.

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

For more information, please visit http://www.smi-online.co.uk.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sonal Patel

Sonal Patel
SMi Group Ltd
+44-207-827-6106
Email >
Follow us on
Visit website